Pages
- Home
- ADHD and you
- Burden of ADHD
- Assessment & diagnosis
- Disease management
- Meetings & events
- On-demand events
- Webinar: Adult ADHD and comorbid borderline personality disorder webinar
- Webinar: Adult ADHD and comorbid substance-use disorder
- Webinar: Neurobiology of ADHD
- Webinar: Adult ADHD and comorbid anxiety disorders webinar
- Webinar: Adult ADHD and comorbid major depressive disorder webinar
- Webinar: Adult ADHD and comorbid bipolar disorder webinar
- ADHD Institute meetings
- A selection of clinical seminars – advancing the management of ADHD across the lifespan
- Day 1 ‒ Advancing the management of ADHD across the lifespan
- Day 2 ‒ Advancing the management of ADHD across the lifespan
- Day 1 – Advancing the science and clinical perspectives of ADHD across the life-course
- Day 2 – Advancing the science and clinical perspectives of ADHD across the life-course
- A selection of clinical seminars – Advancing the science and clinical perspectives of ADHD across the life-course
- Day 1 – Changes, challenges and complexities: ADHD across the life-course
- Day 2 – Changes, challenges and complexities: ADHD across the life-course
- A selection of clinical seminars – Changes, challenges and complexities: ADHD across the life-course
- Congress reports
- 28th European Congress of Psychiatry (EPA) Virtual Congress
- UKAAN meeting: Delivering cost-effective services to adults with ADHD
- Day 1: 5th EUNETHYDIS International Conference on ADHD
- Day 2: 5th EUNETHYDIS International Conference on ADHD
- Day 3: 5th EUNETHYDIS International Conference on ADHD
- Day 4: 5th EUNETHYDIS International Conference on ADHD
- Day 1: From child to adult disorder
- Day 2: From child to adult disorder
- Day 3: From child to adult disorder
- Day 4: From child to adult disorder
- Key congresses 2020
- On-demand events
- Publications & expert insights
- Publications 2020
- Expert insight
- Transition in ADHD by Dr Kuben Naidoo
- Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 1: Evaluation
- Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 2: Treatment plans for children and adolescents
- ADHD services in paediatric neurodisability in Sheffield, UK by Dr Val Harpin & Dr Caroline Bleakley
- Takeda in ADHD
- Contact us
- Terms of use
- Privacy notice
- Register
- Search
- Sitemap
Posts by category
- Category: Publications 2018
- Advances in ADHD research over the past 20 years
- The overlap between ADHD, conduct disorder and addiction: a causal model
- The co-occurrence and familial co-aggregation of borderline personality disorder and ADHD in a Swedish population
- Is there a link between screen media use and ADHD?
- The Canadian Paediatric Society releases new position statements on child and adolescent ADHD
- Global trends and prevalence of ADHD medication use
- Analysis of the MTA study: do children diagnosed with hyperkinetic disorder have poorer outcomes in adulthood?
- Outcomes for adults with bipolar disorder and ADHD
- How does ADHD change throughout a lifespan?
- A practical approach to identifying and treating ADHD in prisoners
- A review of novel ADHD genetic discoveries in the 21st century
- Refining short-term pharmacological treatment choices for ADHD
- Prevalence of ADHD in detention settings: an update
- Predicting adult functional outcomes in boys with ADHD
- Are there sex differences in ADHD trajectories across childhood and adolescence?
- What prevents practitioners from discussing and implementing drug holidays in children and adolescents with ADHD?
- Children with ADHD and sociodemographic disadvantages are more likely to display academic and school-based social impairments
- Is there an association between ADHD and asthma?
- Transition into adulthood may be delayed in emerging adults with ADHD symptoms
- How is health-related quality of life affected by a diagnosis of ADHD in adulthood?
- An evidence-based guide to treatment selection for ADHD
- Are ADHD medications under- or over-prescribed worldwide? Protocol for a systematic review and meta-analysis
- Personality disorders, traits and profiles in adults with ADHD
- Do brain disorders share common genetic risk factors?
- Health-related and economic impact of ADHD in a Scottish prison
- Category: Publications 2019
- Viewpoint: should the ADHD diagnostic criteria be revised?
- What do clinicians involved in transitioning adolescents with ADHD from child to adult services think about the recommendations from the NICE guidelines?
- Clinical practice and opinions of adult ADHD in Germany
- Prediction of current and retrospective symptoms of ADHD in adolescence and adulthood using virtual reality
- Practical considerations for adult ADHD: a French perspective
- How does a diagnosis of ADHD affect children with hyperactivity/inattention symptoms?
- Developmental and environmental factors in adolescence may contribute to symptoms of late-onset ADHD
- The effect of long-term stimulant medication on growth trajectories in children with ADHD: results from the MTA study
- Use of two surveillance methods to estimate the need for transition between child and adult mental health services in young people with ADHD in the UK
- Waiting times from referral to ADHD diagnosis for children and adolescents in Italy
- Public perception of ADHD in children and adults: a German population study
- A methodological approach to mapping adult ADHD services in the UK
- Are there cross-country differences in parental reporting of ADHD symptoms?
- Results from the MTA study: is there a link between depression and ADHD-related risk for substance use in adolescence and early adulthood?
- “I’ve got a text!” Use of a novel text messaging intervention in adults with ADHD to improve adherence to stimulants
- The efficacy of non-pharmacological interventions on internalising symptoms associated with ADHD
- Exploring the impact of ADHD on the daily lives of adults currently taking ADHD medication
- Adherence to stimulant medication in children and adolescents with ADHD
- Recommendations by the European ADHD Guidelines Group for pharmacotherapy research on ADHD
- Examining the transition from child to adult support services for young people with ADHD in the UK and Republic of Ireland
- Predictors of ADHD persistence: a 9-year follow-up study
- Impact of ADHD on athletes and the effects of sport participation on ADHD
- The impact of ADHD in elite athletes
- Exposure to the natural environment, rurality and children with ADHD in New Zealand
- Identification of an ocular biomarker for children with ADHD?
- Guidelines for the development of technological interventions for the self-management of ADHD in children and adolescents
- An investigation into the resumption of ADHD medication in early adulthood in UK primary care
- The effects of a sibling-mediated intervention on social skills in young children with ADHD
- How accurate is self-reported recall of childhood symptoms of ADHD?
- Adolescent ADHD and smartphone addiction: development and validation of a parental management scale
- The validity of a parent questionnaire for rating ADHD symptoms in children
- Is there a link between childhood maltreatment and ADHD?
- The recognition and treatment of adult ADHD in European psychiatric patients
- An investigation into the stigma associated with childhood ADHD
- Is ADHD distorted in the French media?
- Prescribing patterns for young people with ADHD in the UK primary care setting
- Psychiatric comorbidities in adults with ADHD: the effects of treatment and ADHD subtype
- Investigating the relationship between sociodemographic risk factors and ADHD in children
- How does raising a child with ADHD affect the child’s parents?
- The high economic burden of ADHD and psychiatric comorbidities throughout the lifespan
- Is there a genetic correlation between ADHD and cannabis use?
- Association between ADHD symptoms and perception of mental health discrimination among adults with ADHD in England
- How do adolescents with ADHD use and interact with the internet?
- A critical review of the 2018 update to the NICE guideline on pharmacological treatment of ADHD
- What are the barriers and facilitators affecting access to optimal ADHD care?
- Category: Publications 2020
- Culturally responsive approaches for addressing ADHD
- The neuroscience of ADHD and ASD: the ENIGMA adventure
- ADHD and COVID-19: challenges and opportunities for management in Ireland
- Low treatment rates of young adults with ADHD across the UK
- Starting ADHD medications during the COVID-19 pandemic
- ADHD in adults aged ≥50 years: being different but striving to seem normal
- Children with ADHD and friendship quality
- ‘Lifestyles of the rich and famous’ with ADHD
- The risk for affective temperament, hypomania and suicide in adults with ADHD
- How can ADHD be managed during the COVID-19 pandemic?
- Stakeholder perspectives of ADHD awareness in primary care
- Healthcare utilisation trajectories and the economic impact of comorbidities in young adults with childhood ADHD
- The impact of ADHD in criminal law
- Do early ADHD symptoms predict eating behaviours in later childhood?
- Reciprocal developmental relationship between ADHD and anxiety during adolescence
- Does cannabis use affect the cognitive performance and symptoms of ADHD in adults?
- What differentiates children with ADHD symptoms who do and do not receive a formal diagnosis?
- How are children with ADHD managed in primary care as they mature through adolescence?
- “I’ve got a text!” – use of a novel text-messaging intervention in children with ADHD to improve adherence to stimulants
- Does treatment duration affect the efficacy of pharmacological treatments for ADHD?
- Childhood predictors of de novo and subthreshold late-onset ADHD
- Optimising transition of care for young people with ADHD
- A review of ADHD in light of scientific advances
- What have we learned about the management of childhood ADHD 20 years after the initiation of the MTA study?
- Unmet care needs of children and adolescents with ADHD in specialised mental health care settings in the Netherlands
